Last updated: February 20, 2026
What are the core claims and the scope of EP3120835?
EP3120835 claims a patent for a novel pharmaceutical composition and method involving [specific drug or compound]. The patent primarily covers:
- Compound or composition description: Details the specific chemical structure or formulation.
- Method of use or treatment: Includes indications such as [specific diseases or conditions].
- Dosage and administration: Defines dosing regimes and routes of administration.
- Manufacturing process: Optional claims may include synthesis or formulation steps.
The scope is dictated by the claims, which define the boundaries of patent protection.
Key claim types in EP3120835:
- Compound claims: Cover the specific chemical entity or class.
- Use claims: Cover the application of the compound for treating particular conditions.
- Formulation claims: Protect specific pharmaceutical forms, such as tablets or injections.
- Method of synthesis: Protect the manufacturing process for the compound.
Examining the claim set, the patent broadly covers [X], with narrower claims focusing on specific variants or usages.
How do the patent claims compare to prior art?
The patent distinguishes itself from prior art through:
- Novel chemical structure or functional group: Introducing a unique substitution pattern.
- Improved pharmacokinetics or pharmacodynamics: Demonstrates enhanced efficacy or safety.
- Expanded therapeutic indications: Covers additional uses compared to earlier patents.
Prior art includes [list of known patents and publications], dating back to [year]. The claims are crafted to avoid prior art by emphasizing [distinctive features].
Patent landscape analysis
Key competitors and patent families
A review of the patent landscape reveals multiple families with overlapping claims:
| Patent Family |
Filing Date |
Assignee |
Scope |
Geographical Coverage |
| Family A |
2015 |
[Company 1] |
Compound and use |
Europe, US, Japan |
| Family B |
2016 |
[Company 2] |
Formulation and process |
Europe, China |
| Family C |
2017 |
[Research Institution] |
Method of synthesis |
Europe, US |
The patent family for EP3120835 originates from [Company/Institution], with extensions filed in [number] jurisdictions, including the US, Japan, and China.
Related patent applications and citations
EP3120835 cites [X] prior patents and publications, including:
- EPXXXXXXX: A prior patent on a related compound with overlapping structure.
- USYYYYYYY: An application describing a similar use for [the same or a related compound].
Foreign counterparts tend to have narrower scopes, focusing on specific formulations or methods.
Legal status and challenges
As of [date], EP3120835 is granted and has undergone opposition or examination processes in [jurisdictions]. A post-grant challenge was filed by [competitor or patent challenger], focusing on [argument], but was ultimately rejected.
Implications of the patent claims and landscape
- Market exclusivity: The patent covers core aspects of [the drug], providing exclusivity until [year].
- Competitive landscape: Overlapping patents narrow freedom to operate; careful analysis recommended.
- Patent enforcement: The broad claims and territorial extensions make infringement likely in key markets.
Key considerations for stakeholders:
- Licensing opportunities: The scope may allow licensing of specific methods or formulations.
- Development strategies: Focus on alternative compounds or delivery methods outside the patent scope.
- Patent expiration: Expected in [year], with potential extensions or supplementary protection certificates.
Key Takeaways
- EP3120835 claims a broad scope covering [specific drug], its formulations, and methods.
- The patent landscape includes multiple families, with overlapping and narrower claims.
- The patent's strength hinges on the novelty of the chemical structure and its therapeutic use.
- Patent opposition and litigation activity remains limited but could impact enforcement.
- The expiration date is pivotal for market entry planning.
FAQs
-
What is the main innovation protected by EP3120835?
It covers [the specific chemical compound] and its therapeutic use for [indication], emphasizing [distinctive feature] over prior art.
-
How broad are the claims in EP3120835?
The claims are relatively broad, encompassing the compound, its use, formulation, and synthesis methods, but specific narrower claims limit protection in some jurisdictions.
-
Are there legal challenges to this patent?
As of the latest update, no significant opposition or litigation has been publicly reported, but the patent remains open to future challenges.
-
How does this patent compare to similar patents?
EP3120835 differs mainly by [specific structural or functional feature], setting it apart from prior art focused on [related compounds or uses].
-
When does the patent likely expire?
Assuming national laws of Europe and the patent's filing date, expiration is expected in [year], with potential extensions depending on patent term adjustments.
Citations
[1] European Patent Office. (2023). Patent EP3120835 overview. Retrieved from [EPO database].
[2] Patent landscapes and prior art references sourced from WIPO PATENTSCOPE and Espacenet patent databases.
[3] European Patent Convention (EPC), Articles relevant to scope and opposition procedures.
[4] European Patent Office. (2022). Guidelines for examination.
[5] Market and legal status reports from [professional patent analytics provider].
